Katherine Goodrich
Director · Tarsus Pharmaceuticals, Inc.
- 2024
- Jun 29, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Katherine Goodrich files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bobak R. Azamian - $4.69M in TARS purchases and sales in the last 12 months
- William J. Phd Link - $2.62M in TARS purchases and sales in the last 12 months
- Elizabeth Yeu Lin - $2.20M in TARS purchases and sales in the last 12 months
- Seshadri Neervannan - $2.00M in TARS purchases and sales in the last 12 months
- Jeffrey S. Farrow - $1.32M in TARS purchases and sales in the last 12 months
- Aziz Mottiwala - $893K in TARS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Katherine Goodrich?
Katherine Goodrich is a corporate insider, tracked as Director of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Katherine Goodrich last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 5 filings going back to 2024.
Has Katherine Goodrich been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($183K) across all tracked filings.
